In asymptomatic patients with preserved LVEF, both guidelines now endorse consideration of AVR in the presence of high-risk features, such as very severe AS, rapid progression, elevated BNP, or exercise-induced blood pressure drop, particularly in patients with low procedural risk. This evidence concerns the gene NPPB and aortic stenosis.